Skip to main content

Bina Technologies Adds $1.75M to Series B Financing Round

NEW YORK (GenomeWeb News) – Bioinformatics company Bina Technologies added $1.75 million to its Series B financing round, bringing the total raised in the round to $8 million, it said today.

Bina previously announced it raised $6.25 million in the round in March.

The additional funding was led by Mohsen Moazami at Columbus Nova Technology Partners and Jerry Yang, the former Yahoo! co-founder and CEO who now runs his own personal venture firm called AME Cloud Ventures.

The new funds, the Redwood City, Calif.-based company said, will help move Bina in its goal of becoming an integrated genomic analysis platform company to "unlock the potential of DNA-based medicine and biotechnology by delivering fast, accurate, and scalable genomic analysis."

Proceeds from the earlier $6.25 million raise went toward expanding Bina's development, marketing, sales, and support infrastructure.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.